UroGen Pharma URGN Institutional Ownership

NASDAQ URGN

$44.09 -0.79 (-1.76%)

As of: Sep 4, 2026 · 3:59 PM EDT

Institutions by Trading Activity

192 Institutions

Increased 105 54.7%

Unchanged 33 17.2%

Reduced 54 28.1%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

84.47%

▼-8.11 pp QoQ

Shares Held by Institutions

42.56Mn

of 50.38Mn outstanding

▲+4.12% QoQ

Shares Outstanding

50.38Mn

7.82Mn held outside 13F filers

Institutional Investors

192

filed 13F for Jun 2026

▲+20 vs prior quarter

Net Shares Added (QoQ)

+1.68Mn

accumulated since last quarter

Value of Holdings

$1.91Bn

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Quarter ending 30 Jun, 2026

UroGen Pharma Ltd. (NASDAQ:URGN) appears in 192 institutional 13F filings for the quarter ending June 2026.

These investors collectively held 84.5% of UroGen Pharma's outstanding shares in June 2026, down from 92.6% in March 2026.
Their total shares held in URGN increased 4.12% quarter over quarter, and separately, investors owning UroGen Pharma increased 28.86% from a year ago.
Of these 192 funds, 105 grew their exposure to UroGen Pharma, 54 cut back, and 33 maintained positions.
Altogether, these fund groups held 42.56Mn shares in URGN by June 2026, up by 1.68Mn shares quarter on quarter, and up 4.08Mn shares year over year.
RTW INVESTMENTS, LP leads ownership in URGN with 4.54Mn shares as of June 30, 2026, equal to 9.02% of outstanding shares.
The most significant purchases of URGN for the quarter ending June 2026 came from Point72 Asset Management, L.P. (1.53Mn), SG Americas Securities, LLC (395.06K), BlackRock, Inc. (355.89K), Bank Of America Corp /De/ (348.92K), Goldman Sachs Group Inc (221.31K).
The largest sales of URGN for the quarter ending June 2026 came from J. Goldman & Co LP (726.1K), MILLENNIUM MANAGEMENT LLC (264.21K), CITADEL ADVISORS LLC (255.01K), SILVERARC CAPITAL MANAGEMENT, LLC (201.07K), ORBIMED ADVISORS LLC (199.3K).
Per Business Quant data, the top 10 holders of UroGen Pharma for the quarter ending June 2026 are RTW INVESTMENTS, LP (4.54Mn), BlackRock, Inc. (3.2Mn), Morgan Stanley (2.58Mn), Kynam Capital Management, LP (2.43Mn), Jefferies Financial Group Inc. (2.2Mn), SG Americas Securities, LLC (2.05Mn), AMERICAN CENTURY COMPANIES INC (1.69Mn), ACORN CAPITAL ADVISORS, LLC (1.67Mn), Point72 Asset Management, L.P. (1.53Mn), FRONTIER CAPITAL MANAGEMENT CO LLC (1.51Mn).

Form 13F Holdings

192 Institutional Holders

Report period 30 Jun, 2026

Total shares held 42.56Mn

Of outstanding 84.47%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	RTW INVESTMENTS, LP	0001493215	4,543,895	9.02%	0	0.00%	$167.22Mn
2	BlackRock, Inc.	0002012383	3,201,461	6.35%	▲355,894	+12.51%	$117.81Mn
3	Morgan Stanley	0000895421	2,576,363	5.11%	▲16,325	+0.64%	$94.81Mn
4	Kynam Capital Management, LP	0001907884	2,434,207	4.83%	▲186,814	+8.31%	$89.58Mn
5	Jefferies Financial Group Inc.	0000096223	2,199,652	4.37%	0	0.00%	$80.95Mn
6	SG Americas Securities, LLC	0001313360	2,052,906	4.07%	▲395,060	+23.83%	$75.55K
7	AMERICAN CENTURY COMPANIES INC	0000748054	1,685,719	3.35%	▲48,149	+2.94%	$62.03Mn
8	ACORN CAPITAL ADVISORS, LLC	0002054410	1,673,420	3.32%	0	0.00%	$61.58Mn
9	Point72 Asset Management, L.P.	0001603466	1,525,549	3.03%	▲1,525,549	0.00%	$56.14Mn
10	FRONTIER CAPITAL MANAGEMENT CO LLC	0000351173	1,508,547	2.99%	▲194,435	+14.80%	$55.51Mn
11	Opaleye Management Inc.	0001595855	1,439,996	2.86%	▲9,996	+0.70%	$52.99Mn
12	SILVERARC CAPITAL MANAGEMENT, LLC	0001816307	1,301,979	2.58%	▼201,066	-13.38%	$47.91Mn
13	MENORA MIVTACHIM HOLDINGS LTD.	0001351917	1,152,531	2.29%	0	0.00%	$42.41Mn
14	D. E. Shaw & Co., Inc.	0001009207	1,145,819	2.27%	▲122,660	+11.99%	$42.17Mn
15	State Street Corp	0000093751	1,003,071	1.99%	▲128,895	+14.74%	$36.91Mn
16	MPM BioImpact LLC	0001687078	933,415	1.85%	▼10,388	-1.10%	$34.35Mn
17	Soleus Capital Management, L.P.	0001802630	829,810	1.65%	▲102,810	+14.14%	$30.54Mn
18	Goldman Sachs Group Inc	0000886982	819,834	1.63%	▲221,306	+36.98%	$30.17Mn
19	Migdal Insurance & Financial Holdings Ltd.	0001415912	770,909	1.53%	0	0.00%	$28.37Mn
20	ORBIMED ADVISORS LLC	0001055951	676,187	1.34%	▼199,300	-22.76%	$24.88Mn

Showing 1 to 20 of 192 holders